{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:36:21Z","timestamp":1789677381714,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hormozgan University of Medical Sciences, Bandar Abbas, Iran..","award":["4010550"],"award-info":[{"award-number":["4010550"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01946-y","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T01:40:47Z","timestamp":1764034847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FGD5-AS1 and Th1\/Th2 imbalance in the progression of diabetic nephropathy: evidence from bioinformatic and experimental validation"],"prefix":"10.1007","volume":"26","author":[{"given":"Parisa","family":"Ajorlou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amirhossein","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Ghanbarnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shekari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"1946_CR1","doi-asserted-by":"publisher","first-page":"1161521","DOI":"10.3389\/fendo.2023.1161521","volume":"14","author":"R Ruze","year":"2023","unstructured":"Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol. 2023;14:1161521.","journal-title":"Front Endocrinol"},{"issue":"17","key":"1946_CR2","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/ijms21176275","volume":"21","author":"U Galicia-Garcia","year":"2020","unstructured":"Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.","journal-title":"Int J Mol Sci"},{"key":"1946_CR3","first-page":"225","volume":"66","author":"S Del Prato","year":"2024","unstructured":"Del Prato S, Bianchi C, Daniele G. Abnormalities of insulin secretion and \u03b2-cell defects in type 2 diabetes. Textb Diabetes. 2024;66:225\u201337.","journal-title":"Textb Diabetes"},{"issue":"7","key":"1946_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377\u201390.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1946_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.14348","volume":"21","author":"S Yan","year":"2024","unstructured":"Yan S, Yao D, Wang Y, Zhang J. Risk factors of foot ulcers in patients with end-stage renal disease on dialysis: a meta-analysis. Int Wound J. 2024;21(1):e14348.","journal-title":"Int Wound J"},{"issue":"7","key":"1946_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1573399818666211117122604","volume":"18","author":"MM Adeva-Andany","year":"2022","unstructured":"Adeva-Andany MM, Fern\u00e1ndez-Fern\u00e1ndez C, Funcasta-Calder\u00f3n R, Ameneiros-Rodr\u00edguez E, Adeva-Contreras L, Castro-Quintela E. Insulin resistance is associated with clinical manifestations of diabetic kidney disease (glomerular hyperfiltration, albuminuria, and kidney function decline). Curr Diabetes Rev. 2022;18(7):64\u201385.","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"1946_CR7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00125-023-05891-x","volume":"66","author":"A Kautzky-Willer","year":"2023","unstructured":"Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66(6):986\u20131002.","journal-title":"Diabetologia"},{"key":"1946_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.649587","volume":"12","author":"B-Y Shao","year":"2021","unstructured":"Shao B-Y, Zhang S-F, Li H-D, Meng X-M, Chen H-Y. Epigenetics and inflammation in diabetic nephropathy. Front Physiol. 2021;12:649587.","journal-title":"Front Physiol"},{"key":"1946_CR9","doi-asserted-by":"publisher","first-page":"1084448","DOI":"10.3389\/fimmu.2023.1084448","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lv Y, Zhang T, Huang T, Lang Y, Sheng Q, et al. T cells and their products in diabetic kidney disease. Front Immunol. 2023;14:1084448.","journal-title":"Front Immunol"},{"issue":"8","key":"1946_CR10","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.ymthe.2022.04.024","volume":"30","author":"L Li","year":"2022","unstructured":"Li L, Tang W, Zhang Y, Jia M, Wang L, Li Q, et al. Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis. Mol Ther. 2022;30(8):2746\u201359.","journal-title":"Mol Ther"},{"issue":"1","key":"1946_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-025-01802-z","volume":"25","author":"SA Hosseini","year":"2025","unstructured":"Hosseini SA, Ajorlou P, Mousavi P, Shekari M. Revealing the regulatory role of lncRNAs SNHG1 and CRNDE on Th17\/Treg imbalance in diabetic kidney disease. Clin Exp Med. 2025;25(1):1\u201315.","journal-title":"Clin Exp Med"},{"key":"1946_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2025.115965","author":"SA Hosseini","year":"2025","unstructured":"Hosseini SA, Ajorlou P, Haddadian H, Sohrabipour S. Itgb3 as a promising non-invasive biomarker for type 2 diabetes and diabetic nephropathy. Anal Biochem. 2025. https:\/\/doi.org\/10.1016\/j.ab.2025.115965.","journal-title":"Anal Biochem"},{"issue":"08","key":"1946_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/CM9.0000000000000748","volume":"133","author":"X-M Zhang","year":"2020","unstructured":"Zhang X-M, Liu C-Y, Shao Z-H. Advances in the role of helper T cells in autoimmune diseases. Chin Med J. 2020;133(08):968\u201374.","journal-title":"Chin Med J"},{"issue":"21","key":"1946_CR14","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.3390\/ijms21218011","volume":"21","author":"X Zhu","year":"2020","unstructured":"Zhu X, Zhu J. CD4 t helper cell subsets and related human immunological disorders. Int J Mol Sci. 2020;21(21):8011.","journal-title":"Int J Mol Sci"},{"key":"1946_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","volume":"39","author":"C Dong","year":"2021","unstructured":"Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol. 2021;39:51\u201376.","journal-title":"Annu Rev Immunol"},{"key":"1946_CR16","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e4","author":"GR Lee","year":"2023","unstructured":"Lee GR. Molecular mechanisms of T helper cell differentiation and functional specialization. Immune Netw. 2023. https:\/\/doi.org\/10.4110\/in.2023.23.e4.","journal-title":"Immune Netw"},{"key":"1946_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154892","volume":"126","author":"T Mahlangu","year":"2020","unstructured":"Mahlangu T, Dludla PV, Nyambuya TM, Mxinwa V, Mazibuko-Mbeje SE, Cirilli I, et al. A systematic review on the functional role of Th1\/Th2 cytokines in type 2 diabetes and related metabolic complications. Cytokine. 2020;126:154892.","journal-title":"Cytokine"},{"key":"1946_CR18","volume":"43","author":"SAH Hosseini","year":"2025","unstructured":"Hosseini SAH, Ajorlou P, Salehian M, Dehghani A. LncRNAs IFNG-AS1 and TH2LCRR as potential biomarkers of Th1\/Th2 imbalance in diabetic nephropathy: from bioinformatics to experimental validation. Biochem Biophys Rep. 2025;43:102093.","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"1946_CR19","first-page":"1","volume":"6","author":"T Mitiku","year":"2024","unstructured":"Mitiku T, Abebe B. Molecular mechanism of long noncoding RNAs that involves on regulation of the immune system and gene expression. Asian J Res Biosci. 2024;6(1):1\u201316.","journal-title":"Asian J Res Biosci"},{"key":"1946_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.626423","volume":"8","author":"X He","year":"2021","unstructured":"He X, Kuang G, Zuo Y, Li S, Zhou S, Ou C. The role of non-coding RNAs in diabetic nephropathy-related oxidative stress. Front Med. 2021;8:626423.","journal-title":"Front Med"},{"key":"1946_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5857214","author":"G Liu","year":"2021","unstructured":"Liu G, Du X, Xiao L, Zeng Q, Liu Q. Activation of fgd5-as1 promotes progression of cervical cancer through regulating bst2 to inhibit macrophage m1 polarization. J Immunol Res. 2021. https:\/\/doi.org\/10.1155\/2021\/5857214.","journal-title":"J Immunol Res"},{"issue":"2","key":"1946_CR22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/ijmm.2020.4816","volume":"47","author":"F Zhu","year":"2021","unstructured":"Zhu F, Niu R, Shao X, Shao X. FGD5-AS1 promotes cisplatin resistance of human lung adenocarcinoma cell via the miR-142-5p\/PD-L1 axis. Int J Mol Med. 2021;47(2):523\u201332.","journal-title":"Int J Mol Med"},{"key":"1946_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215751","volume":"548","author":"Z He","year":"2022","unstructured":"He Z, Wang J, Zhu C, Xu J, Chen P, Jiang X, et al. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Lett. 2022;548:215751.","journal-title":"Cancer Lett"},{"key":"1946_CR24","doi-asserted-by":"publisher","first-page":"1035111","DOI":"10.3389\/fimmu.2022.1035111","volume":"13","author":"P Chattopadhyay","year":"2022","unstructured":"Chattopadhyay P, Mishra P, Mehta P, Soni J, Gupta R, Tarai B, et al. Transcriptomic study reveals lncRNA-mediated downregulation of innate immune and inflammatory response in the SARS-CoV-2 vaccination breakthrough infections. Front Immunol. 2022;13:1035111.","journal-title":"Front Immunol"},{"issue":"1","key":"1946_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13098-022-00789-x","volume":"14","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang J. Diagnostic significance of serum FGD5-AS1 and its predictive value for the development of cardiovascular diseases in patients with type 2 diabetes. Diabetol Metab Syndr. 2022;14(1):20.","journal-title":"Diabetol Metab Syndr"},{"key":"1946_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"66","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T. The gene expression omnibus database. Stat Genomics: Methods Protoc. 2016;66:93\u2013110.","journal-title":"Stat Genomics: Methods Protoc"},{"issue":"D1","key":"1946_CR27","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkaa1046","volume":"49","author":"L Zhao","year":"2021","unstructured":"Zhao L, Wang J, Li Y, Song T, Wu Y, Fang S, et al. NONCODEV6: an updated database dedicated to long non-coding RNA annotation in both animals and plants. Nucleic Acids Res. 2021;49(D1):D165\u201371.","journal-title":"Nucleic Acids Res"},{"key":"1946_CR28","doi-asserted-by":"publisher","first-page":"1333170","DOI":"10.3389\/fimmu.2024.1333170","volume":"15","author":"XM Hao","year":"2024","unstructured":"Hao XM, Liu Y, Hailaiti D, Gong Y, Zhang XD, Yue BN, et al. Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy. Front Immunol. 2024;15:1333170.","journal-title":"Front Immunol"},{"issue":"3","key":"1946_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1626","volume":"14","author":"M Barberis","year":"2024","unstructured":"Barberis M, Rojas L\u00f3pez A. Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: tipping the balance of T- and B-cell interactions. Clin Transl Med. 2024;14(3):e1626.","journal-title":"Clin Transl Med"},{"key":"1946_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/genes15010123","author":"LA Bravo-V\u00e1zquez","year":"2024","unstructured":"Bravo-V\u00e1zquez LA, Paul S, Col\u00edn-Jurado MG, M\u00e1rquez-Gallardo LD, Casta\u00f1\u00f3n-Cort\u00e9s LG, Banerjee A, et al. Exploring the therapeutic significance of microRNAs and lncRNAs in kidney diseases. Genes. 2024. https:\/\/doi.org\/10.3390\/genes15010123.","journal-title":"Genes"},{"issue":"11","key":"1946_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nri3536","volume":"13","author":"V Lazarevic","year":"2013","unstructured":"Lazarevic V, Glimcher LH, Lord GM. T-bet: a bridge between innate and adaptive immunity. Nat Rev Immunol. 2013;13(11):777\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1946_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","volume":"5","author":"MB Duran-Salgado","year":"2014","unstructured":"Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014;5(3):393.","journal-title":"World J Diabetes"},{"key":"1946_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155394","volume":"138","author":"K Amirshahrokhi","year":"2021","unstructured":"Amirshahrokhi K, Zohouri A. Carvedilol prevents pancreatic \u03b2-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-\u03baB, COX-2, iNOS and oxidative stress. Cytokine. 2021;138:155394.","journal-title":"Cytokine"},{"issue":"1","key":"1946_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4049\/jimmunol.0804154","volume":"183","author":"JH Esensten","year":"2009","unstructured":"Esensten JH, Lee MR, Glimcher LH, Bluestone JA. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function. J Immunol. 2009;183(1):75\u201382.","journal-title":"J Immunol"},{"key":"1946_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/v16020281","author":"P Petakh","year":"2024","unstructured":"Petakh P, Kamyshna I, Oksenych V, Kamyshnyi O. Metformin alters mRNA expression of FOXP3, RORC, and TBX21 and modulates gut microbiota in COVID-19 patients with type 2 diabetes. Viruses. 2024. https:\/\/doi.org\/10.3390\/v16020281.","journal-title":"Viruses"},{"issue":"4","key":"1946_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","volume":"75","author":"C Zhang","year":"2014","unstructured":"Zhang C, Xiao C, Wang P, Xu W, Zhang A, Li Q, et al. The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Hum Immunol. 2014;75(4):289\u201396.","journal-title":"Hum Immunol"},{"key":"1946_CR37","doi-asserted-by":"publisher","first-page":"22081","DOI":"10.1038\/srep22081","volume":"6","author":"RX Leng","year":"2016","unstructured":"Leng RX, Pan HF, Liu J, Yang XK, Zhang C, Tao SS, et al. Evidence for genetic association of TBX21 and IFNG with systemic lupus erythematosus in a Chinese Han population. Sci Rep. 2016;6:22081.","journal-title":"Sci Rep"},{"issue":"5","key":"1946_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-3083.2011.02520.x","volume":"73","author":"JR Li","year":"2011","unstructured":"Li JR, Li JG, Deng GH, Zhao WL, Dan YJ, Wang YM, et al. A common promoter variant of TBX21 is associated with allele specific binding to Yin-Yang 1 and reduced gene expression. Scand J Immunol. 2011;73(5):449\u201358.","journal-title":"Scand J Immunol"},{"issue":"9\u201310","key":"1946_CR39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cca.2010.01.036","volume":"411","author":"CC Wu","year":"2010","unstructured":"Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, et al. Aberrant cytokines\/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy. Clin Chim Acta. 2010;411(9\u201310):700\u20134.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1946_CR40","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/mt.2013.235","volume":"22","author":"HY Chen","year":"2014","unstructured":"Chen HY, Zhong X, Huang XR, Meng XM, You Y, Chung AC, et al. Microrna-29b inhibits diabetic nephropathy in db\/db mice. Mol Ther. 2014;22(4):842\u201353.","journal-title":"Mol Ther"},{"issue":"7","key":"1946_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/intimm\/dxr029","volume":"23","author":"R Yagi","year":"2011","unstructured":"Yagi R, Zhu J, Paul WE. An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation. Int Immunol. 2011;23(7):415\u201320.","journal-title":"Int Immunol"},{"issue":"5","key":"1946_CR42","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/ndt\/gfw271","volume":"32","author":"H Belge","year":"2017","unstructured":"Belge H, Dahan K, Cambier JF, Benoit V, Morelle J, Bloch J, et al. Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome. Nephrol Dial Transplant. 2017;32(5):830\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1946_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/s-0042-106083","volume":"124","author":"H Guo","year":"2016","unstructured":"Guo H, Pan C, Chang B, Wu X, Guo J, Zhou Y, et al. Triptolide improves diabetic nephropathy by regulating Th cell balance and macrophage infiltration in rat models of diabetic nephropathy. Exp Clin Endocrinol Diabetes. 2016;124(6):389\u201398.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"1946_CR44","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.3892\/mmr.2017.7111","volume":"16","author":"A Tang","year":"2017","unstructured":"Tang A, Li C, Chen Z, Li T. Anti-CD20 monoclonal antibody combined with adenovirus vector-mediated IL-10 regulates spleen CD4+\/CD8+ T cells and T-bet\/GATA-3 expression in NOD mice. Mol Med Rep. 2017;16(4):3974\u201382.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1946_CR45","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2169\/internalmedicine.56.7930","volume":"56","author":"M Kamezaki","year":"2017","unstructured":"Kamezaki M, Kusaba T, Adachi T, Yamashita N, Nakata M, Ota N, et al. Unusual proliferative glomerulonephritis in a patient diagnosed to have hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome with a novel mutation in the GATA3 gene. Intern Med. 2017;56(11):1393\u20137.","journal-title":"Intern Med"},{"issue":"9","key":"1946_CR46","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1681\/ASN.2018111143","volume":"30","author":"IV Grigorieva","year":"2019","unstructured":"Grigorieva IV, Oszwald A, Grigorieva EF, Schachner H, Neudert B, Ostendorf T, et al. A novel role for GATA3 in mesangial cells in glomerular development and injury. J Am Soc Nephrol. 2019;30(9):1641\u201358.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1946_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/sji.12637","volume":"87","author":"P Lu","year":"2018","unstructured":"Lu P, Ji X, Wan J, Xu H. Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy. Scand J Immunol. 2018;87(2):99\u2013107.","journal-title":"Scand J Immunol"},{"issue":"7","key":"1946_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198507","volume":"13","author":"N Huda","year":"2018","unstructured":"Huda N, Hosen MI, Yasmin T, Sarkar PK, Hasan A, Nabi A. Genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population. PLoS ONE. 2018;13(7):e0198507.","journal-title":"PLoS ONE"},{"issue":"1","key":"1946_CR49","first-page":"1","volume":"47","author":"W-T Zhang","year":"2022","unstructured":"Zhang W-T, Zhang J-J, Shao Q, Wang Y-K, Jia J-P, Qian B, et al. FGD5-AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt\/\u03b2-catenin signaling pathway via miR-577. Oncol Rep. 2022;47(1):1\u201311.","journal-title":"Oncol Rep"},{"key":"1946_CR50","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202009_22814","author":"Y Yang","year":"2020","unstructured":"Yang Y, Dong M-H, Hu H-M, Min Q-H, Xiao L. LncRNA FGD5-AS1\/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK\/AKT signalling. Eur Rev Med Pharmacol Sci. 2020. https:\/\/doi.org\/10.26355\/eurrev_202009_22814.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"1946_CR51","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1080\/21655979.2022.2067292","volume":"13","author":"N He","year":"2022","unstructured":"He N, Xiang L, Chen L, Tong H, Wang K, Zhao J, et al. The role of long non-coding RNA FGD5-AS1 in cancer. Bioengineered. 2022;13(4):11026\u201341.","journal-title":"Bioengineered"},{"key":"1946_CR52","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12424","author":"Y Chu","year":"2021","unstructured":"Chu Y, Wang X, Yu N, Li Y, Kan J. Long non-coding RNA FGD5-AS1\/microRNA-133a-3p upregulates aquaporin 1 to decrease the inflammatory response in LPS-induced sepsis. Mol Med Rep. 2021. https:\/\/doi.org\/10.3892\/mmr.2021.12424.","journal-title":"Mol Med Rep"},{"issue":"3","key":"1946_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000534985","volume":"185","author":"B Li","year":"2024","unstructured":"Li B, Yu X, Pang F. LncRNA FGD5-AS1 alleviates inflammation in allergic rhinitis through the miR-223-3p\/COX11 axis. Int Arch Allergy Immunol. 2024;185(3):201\u201311.","journal-title":"Int Arch Allergy Immunol"},{"key":"1946_CR54","doi-asserted-by":"publisher","DOI":"10.1007\/s13273-023-00357-y","author":"L Quan","year":"2023","unstructured":"Quan L, Jin Y, Wang J, Dai X, Zhu S, Sheng Z. FGD5-AS1 promotes growth and mobility of trophoblast cells by regulating IGF2 via sponging miR-16-5p in pre-eclampsia. Mol Cell Toxicol. 2023. https:\/\/doi.org\/10.1007\/s13273-023-00357-y.","journal-title":"Mol Cell Toxicol"},{"key":"1946_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147751","volume":"1776","author":"F Jiang","year":"2022","unstructured":"Jiang F, Liu X, Wang X, Hu J, Chang S, Cui X. LncRNA FGD5-AS1 accelerates intracerebral hemorrhage injury in mice by adsorbing miR-6838-5p to target VEGFA. Brain Res. 2022;1776:147751.","journal-title":"Brain Res"},{"issue":"1","key":"1946_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113481","volume":"424","author":"Q Sun","year":"2023","unstructured":"Sun Q, Liu X, Wang M, Fan J, Zeng H. Long noncoding RNA FGD5-AS1 alleviates childhood IgA nephropathy by targeting PTEN-mediated JNK\/c-Jun signaling pathway via miR-196b-5p. Exp Cell Res. 2023;424(1):113481.","journal-title":"Exp Cell Res"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01946-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01946-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01946-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:03:26Z","timestamp":1764079406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01946-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01946-y","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no disclosed conflicts of interest for the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflcit of interest"}},{"value":"Approval for this research was granted by the Local Medical Ethics Committee (IR.HUMS.REC.1402.055), which the authors hereby confirm.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical conduct of research"}},{"value":"Consent forms were signed by all individuals who took part in the research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"38"}}